kollaGen II-xs
Clinical Trial conducted by Morton Scientific Group, Cambridge, Ontario, Canada

The study also showed a normalizing of saliva pH levels which is often indicative of a reduction in inflammation.

The study results showed that KollaGen II-xs™ taken at a dosage of 375mg – 500mg twice a day appears to provide soothing properties to the joints, secondary mobility and other tertiary effects.

Clinical data adopted from Certified Nutraceuticals Inc.
https://www.certifiednutra.com/products-kollagen_IIxs.php

Shopping cart
There are no products in the cart!
Continue shopping
0